The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging

Semin Ultrasound CT MR. 2013 Feb;34(1):44-53. doi: 10.1053/j.sult.2012.11.004.

Abstract

Hepatocyte-specific contrast agents have been made available in the last 15 years for magnetic resonance imaging of the liver. These agents are differentially taken up by functioning hepatocytes and excreted in the biliary system. They can help distinguish focal liver lesions of hepatocellular origin from lesions of nonhepatocellular origin, and can also be used in the evaluation of the biliary tree. The purpose of this review is to summarize the different types of hepatocyte-specific contrast agents presently available, their use in the characterization of focal liver lesions, their role in the evaluation of biliary pathology, and their potential future applications.

Publication types

  • Review

MeSH terms

  • Bile Duct Neoplasms / diagnosis*
  • Bile Ducts / pathology
  • Contrast Media*
  • Edetic Acid / analogs & derivatives
  • Gadolinium DTPA
  • Hepatocytes
  • Humans
  • Image Enhancement / methods*
  • Liver / pathology
  • Liver Neoplasms / diagnosis*
  • Magnetic Resonance Imaging / methods*
  • Meglumine / analogs & derivatives
  • Organometallic Compounds
  • Pyridoxal Phosphate / analogs & derivatives

Substances

  • Contrast Media
  • Organometallic Compounds
  • gadolinium ethoxybenzyl DTPA
  • gadobenic acid
  • Pyridoxal Phosphate
  • Meglumine
  • Edetic Acid
  • Gadolinium DTPA
  • N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid